Proportion of subjects achieving a clinically significant response measured by the proportion of subjects who are "minimally improved", "much improved" or "very much improved" on the Patient's Global Impression of Change (PGIC)

On a stable dose of antibiotics and/or analgesics for at least 4 weeks (if already taking these medications)

Average pain score of 3-9.

Exclusion Criteria:

History of cyclic neutropenia

Laboratory assessment abnormalities

Underlying disorder considered unsuitable for inclusion

Other skin diseases that may interfere with HS assessment

Pregnancy or planning for pregnancy

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01838499